DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy

DNAM-1 is a major NK cell activating receptor and, together with NKG2D and NCRs, by binding specific ligands, strongly contributes to mediating the killing of tumor or virus-infected cells. DNAM-1 specifically recognizes PVR and Nectin-2 ligands that are expressed on some virus-infected cells and on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cifaldi, Loredana, Melaiu, Ombretta, Giovannoni, Roberto, Benvenuto, Monica, Focaccetti, Chiara, Nardozi, Daniela, Barillari, Giovanni, Bei, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285446/
https://www.ncbi.nlm.nih.gov/pubmed/37359555
http://dx.doi.org/10.3389/fimmu.2023.1197053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285446/
https://www.ncbi.nlm.nih.gov/pubmed/37359555
http://dx.doi.org/10.3389/fimmu.2023.1197053

Ejemplares similares